APA (7th ed.) Citation

MM, G., TM, A., T, B., C, D., P, G., M, M., . . . A, L. (2023). GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): Psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi randomized controlled clinical trial. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 32(10), 2861. https://doi.org/10.1007/s11136-023-03445-7

Chicago Style (17th ed.) Citation

MM, Gounder, Atkinson TM, Bell T, Daskalopoulou C, Griffiths P, Martindale M, Smith LM, and Lim A. "GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): Psychometric Properties and Clinically Meaningful Thresholds as Assessed in the Phase 3 DeFi Randomized Controlled Clinical Trial." Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 32, no. 10 (2023): 2861. https://doi.org/10.1007/s11136-023-03445-7.

MLA (9th ed.) Citation

MM, Gounder, et al. "GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): Psychometric Properties and Clinically Meaningful Thresholds as Assessed in the Phase 3 DeFi Randomized Controlled Clinical Trial." Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, vol. 32, no. 10, 2023, p. 2861, https://doi.org/10.1007/s11136-023-03445-7.